ArticleMolecular cancer research : MCR2022

Combinatorial Treatment with PARP-1 Inhibitors and Cisplatin Attenuates Cervical Cancer Growth through Fos-Driven Changes in Gene Expression.

Rebecca Gupte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.